Puerto Rico vs Russia: The number of people with susceptibility test result for rifampicin
Puerto Rico
93.33
in 2021
Russia
93.52
in 2021
Puerto Rico rank
58th
Russia rank
57th
The number of people with susceptibility test result for rifampicin over time
- Puerto Rico
- Russia
How they compare
Russia currently reports 93.52 against 93.33 in Puerto Rico, a difference of 0.19.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Puerto Rico ahead.
Puerto Rico ranks 58th and Russia ranks 57th of 146 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Puerto Rico | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.81 | 88.47 | 9.34 | Puerto Rico |
| 2020s | 94.49 | 93.01 | 1.48 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Puerto Rico or Russia?
- Russia, at 93.52 against 93.33 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Puerto Rico and Russia?
- 0.19, with Russia ahead.
- How many years of comparable data are there for Puerto Rico and Russia?
- 5 years are reported by both, from 2017 to 2021.
- How do Puerto Rico and Russia rank globally for the number of people with susceptibility test result for rifampicin?
- Puerto Rico ranks 58th and Russia ranks 57th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.